CD38 and chronic myelogenous leukemia, BCR-ABL1 positive: Genomic instability has been described in CML- chronic phase (CP) and most likely occurs in the LSCs enriched CD34+CD38– population and/or the Leukemic progenitor cell-rich CD34+ population.